Missouri Judge Approves $7.25 Billion Bayer Roundup Settlement

Editorial illustration related to Missouri Judge Approves $7.25 Billion Bayer Roundup Settlement

A Missouri state court judge has approved a $7.25 billion settlement proposed by Bayer AG to resolve tens of thousands of lawsuits in the United States. The litigation centers on claims that the company’s widely used weedkiller, Roundup, is responsible for causing cancer in users.

St. Louis Circuit Judge Timothy Boyer issued the ruling on Friday, November 20, 2026, describing the settlement as “fair, reasonable, and adequate.” The decision marks a significant development for the German conglomerate, which has faced years of legal challenges since its 2018 acquisition of Monsanto, the original manufacturer of Roundup.

Resolution of Long-Running Litigation

The approved Bayer Roundup settlement aims to address a massive volume of claims from individuals who allege that exposure to glyphosate—the active ingredient in Roundup—led to diagnoses of non-Hodgkin lymphoma and other cancers. The legal battle has been a primary contributor to financial instability for the company, which saw its stock price decline significantly in the years following the Monsanto acquisition.

Proponents of the agreement, including many plaintiffs’ attorneys, argued that the deal provides a necessary guarantee of compensation for cancer victims at a time when the legal landscape for these claims has become increasingly volatile. However, some opponents of the settlement contended that the financial terms were insufficient, expressing concern that the deal could limit the ability of current and future claimants to seek higher damages through individual court cases.

Impact of Supreme Court Ruling

The approval of this settlement occurs against the backdrop of a pivotal shift in the legal strategy surrounding glyphosate litigation. Five months prior to Judge Boyer’s ruling, the U.S. Supreme Court delivered a 7-2 decision in favor of Bayer, overturning a $1.25 million jury award in a case involving a Missouri resident who had alleged that Roundup caused his cancer.

In that landmark ruling, the Supreme Court agreed with Bayer’s position that federal law regulating pesticides preempts “failure-to-warn” claims brought under state laws. This decision effectively undercut a central pillar of the plaintiffs’ arguments in many of the cases, providing the company with stronger legal defenses moving forward.

Future of Ongoing Cases

While the $7.25 billion settlement resolves a significant portion of the claims, it does not mark the complete end of the legal trouble for the company. The settlement specifically excludes lawsuits that have been consolidated in separate, ongoing federal court proceedings.

Bayer reports that approximately 200 cases remain in litigation within the federal system. Following the Supreme Court’s ruling earlier this year, the company maintains that it has robust legal arguments to defend against these remaining claims. As the company moves to implement the court-approved settlement, it continues to address the legal and financial pressures that have defined its post-Monsanto operations.